SCHEMBL27869482

SCHEMBL27869482

CC(C)(C)c1cc(C(C)(C)C)c([N+](=O)[O-])cc1COC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
TDP1 Q9NUW8 2/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 4/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GALR3 O60755 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
POLB P06746 1/20 0.36
CHEK1 O14757 1/20 0.35
IMPDH2 P12268 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
GPR35 Q9HC97 1/20 0.34
USP10 Q14694 1/20 0.34
CYP1A2 P05177 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28413275 0.90 ALDH1A1 (0.41) ALDH1A1TDP1TSHRHTTMEN1
SCHEMBL2974514 0.89 ALDH1A1 (0.39) ALDH1A1TDP1TSHRHTTMEN1
SCHEMBL2974516 0.89 ALDH1A1 (0.39) ALDH1A1TDP1TSHRHTTMEN1
SCHEMBL28539174 0.88 ALDH1A1 (0.38) ALDH1A1TDP1TSHRHTTMEN1
SCHEMBL28556722 0.88 MAPT (0.39) ALDH1A1TDP1TSHRHTTMEN1
SCHEMBL377154 0.88 ALDH1A1 (0.38) ALDH1A1TDP1TSHRHTTMEN1
SCHEMBL377153 0.88 ALDH1A1 (0.38) ALDH1A1TDP1TSHRHTTMEN1
SCHEMBL769472 0.87 ALDH1A1 (0.36) ALDH1A1TDP1TSHRHTTMEN1
SCHEMBL769471 0.87 ALDH1A1 (0.36) ALDH1A1TDP1TSHRHTTMEN1
SCHEMBL1787901 0.81 GLRA3 (0.40) ALDH1A1TDP1TSHRHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117924170-A Methods for preparing modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2024-04-26 CN disclosed
CN-111479804-B Methods for preparing modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2023-12-22 CN disclosed
CN-105848657-B Methods of making pharmaceutical compositions for treating CFTR mediated diseases 沃泰克斯药物股份有限公司 2020-05-22 CN disclosed
CN-110267948-A Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and methods of making the modulators 弗特克斯药品有限公司 2019-09-20 CN disclosed
CN-102361855-B Process for the preparation of modulators of cystic fibrosis transmembrane conductance regulator VERTEX PHARMACEUTICALS INC. (US) 2015-09-02 CN disclosed
CN-102665715-A Compositions for treatment of cystic fibrosis and other chronic diseases VERTEX PHARMA 2012-09-12 CN disclosed